These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16159987)

  • 1. Comparison of endothelial vasodilator function, inflammatory markers, and N-terminal pro-brain natriuretic peptide in patients with or without chronotropic incompetence to exercise test.
    Huang PH; Leu HB; Chen JW; Wu TC; Lu TM; Ding YA; Lin SJ
    Heart; 2006 May; 92(5):609-14. PubMed ID: 16159987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise dependence of N-terminal pro-brain natriuretic peptide in patients with precapillary pulmonary hypertension.
    Grachtrup S; Brügel M; Pankau H; Halank M; Wirtz H; Seyfarth HJ
    Respiration; 2012; 84(6):454-60. PubMed ID: 22327025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of combined high-sensitive C-reactive protein and N-terminal-probrain natriuretic peptide for predicting cardiovascular events in patients with suspected coronary artery disease.
    Huang PH; Lu TM; Wu TC; Lin FY; Chen YH; Chen JW; Lin SJ
    Coron Artery Dis; 2008 May; 19(3):187-93. PubMed ID: 18418236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
    Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
    J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of N-terminal pro-brain natriuretic peptide in ST-segment elevation myocardial infarction: experience from a tertiary centre in India.
    Govind SC; Kiotsekoglou A; Gadiyaram VK; Gopal AS; Brodin LÅ; Ramesh SS; Saha SK
    Crit Pathw Cardiol; 2011 Dec; 10(4):180-4. PubMed ID: 22089274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling.
    Saura D; Marín F; Climent V; González J; Roldán V; Hernández-Romero D; Oliva MJ; Sabater M; de la Morena G; Lip GY; Valdés M
    Int J Clin Pract; 2009 Oct; 63(10):1465-71. PubMed ID: 19769703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complimentary roles for N-terminal pro-B-type natriuretic peptide and spirometry to assess functional capacity in patients with complex mixed heart valve disease.
    Bissessor N; Wee YS; Jayasinghe R; Zeng I; Lowe B; Kolbe J; Ellyet K; Kerr A; White H; Stewart R
    Kardiol Pol; 2010 Jan; 68(1):1-10. PubMed ID: 20131183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise-induced increases in NT-proBNP are not related to the exercise-induced immune response.
    Scharhag J; Meyer T; Auracher M; Müller M; Herrmann M; Gabriel H; Herrmann W; Kindermann W
    Br J Sports Med; 2008 May; 42(5):383-5. PubMed ID: 18184752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    Eur Heart J; 2007 Jun; 28(11):1374-81. PubMed ID: 17242007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
    Bode E; Wuppinger T; Bode T; Alber H; Ulmer H; Pachinger O; Mair J
    Coron Artery Dis; 2012 Mar; 23(2):91-7. PubMed ID: 22157356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of physical training on exercise capacity, gas exchange and N-terminal pro-brain natriuretic peptide levels in patients with chronic heart failure.
    Maria Sarullo F; Gristina T; Brusca I; Milia S; Raimondi R; Sajeva M; Maria La Chiusa S; Serio G; Paterna S; Di Pasquale P; Castello A
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):812-7. PubMed ID: 17001223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
    Rothenburger M; Stypmann J; Bruch C; Wichter T; Hoppe M; Drees G; Berendes E; Huelsken G; Loeher A; Welp H; Röttger C; Schmid C; Scheld HH; Tjan TD
    J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
    Shechter M; Issachar A; Marai I; Koren-Morag N; Freinark D; Shahar Y; Shechter A; Feinberg MS
    Int J Cardiol; 2009 May; 134(1):52-8. PubMed ID: 18479768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of absolute and relative exercise-induced changes in B-type natriuretic peptides.
    Maeder MT; Staub D; Surnier Y; Reichlin T; Noveanu M; Breidthardt T; Potocki M; Schaub N; Conen D; Mueller C
    Int J Cardiol; 2011 Mar; 147(3):409-15. PubMed ID: 19897258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic heart failure, chronotropic incompetence, and the effects of beta blockade.
    Witte KK; Cleland JG; Clark AL
    Heart; 2006 Apr; 92(4):481-6. PubMed ID: 16159968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism.
    Ogard CG; Engelmann MD; Kistorp C; Nielsen SL; Vestergaard H
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):493-8. PubMed ID: 16268799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High N-terminal pro-B-type natriuretic peptide: a biomarker of lung cancer?
    Aujollet N; Meyer M; Cailliod R; Combier F; Coignet Y; Campard S; Facy O; Bernard A; Girard C
    Clin Lung Cancer; 2010 Sep; 11(5):341-5. PubMed ID: 20837460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    J Hypertens; 2008 Jan; 26(1):26-34. PubMed ID: 18090537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.